Roche Laboratories Inc. in Nutley, NJ received a maximum $58 million firm-fixed-price contract for Army, Navy, Air Force, and Marine Corps for Oseltamivir Phosphate Capsules. The drug is more popularly known as TAMIFLU, and it is often prescribed in America for the treatment and prevention of influenza. This is a requirements contract with a base year and one option period; the base year expires Feb. 28, 2006. There were two proposals solicited and one responded. The Defense Supply Center Philadelphia in Philadelphia, PA issued the contract (SP0200-05-D-0009).